Shares of ISRG are trading down 4.3% at $417.71 amid news of multiple product recalls for its core da Vinci surgical systems.
- In May 2026, the US FDA announced a Class I recall for the company's SureForm 30 Gray Reloads due to issues with incomplete staple lines.
- Additional recalls have been initiated for components of the da Vinci X and Xi systems because of risks related to screw breakages.
- The news has intensified investor concerns regarding product reliability and the stock's premium valuation.